Feedback / Questions
tolododekin alfa (ANK-101) - Ankyra Therap
https://www.businesswire.com/news/home/20260527127546/en/Ankyra-Therapeutics-Announces-Presentations-on-Novel-IL-12-Anchored-Immunotherapy-at-2026-ASCO
May 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next